Share this article Share this article WEBSTER, Texas, March 15, 2021 /PRNewswire/ -- HTX Urology in Webster, TX (www.htxurology.com) is participating in an FDA cleared research study for a new, minimally invasive device pioneered by Urotronic, Inc., that could dramatically change the way millions of men with enlarged prostates are treated. Urotronic's Optilume® BPH Catheter System is a simple outpatient procedure that combines balloon dilation to open the prostate and local drug delivery designed to maintain symptom relief. Unlike other BPH procedures, it doesn't cut, burn, laser, steam o...